Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
03/2010
03/31/2010CN101687882A Non-basic melanin concentrating hormone receptor-1 antagonists
03/31/2010CN101687873A Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
03/31/2010CN101687827A aminodihydrothiazine derivatives substituted with cyclic groups
03/31/2010CN101684124A Novel compound with blood coagulation resisting function
03/31/2010CN101684123A Preparation method of 2-formamido thienopyridine derivatives and medical uses
03/30/2010US7687627 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
03/30/2010US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders
03/30/2010US7687501 fused tricyclic compounds useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists
03/30/2010US7687086 Method for obtaining taxanes
03/30/2010CA2420894C Thienopyrimidines
03/25/2010WO2010032448A1 Sheet for repairing cartilage defect site
03/25/2010US20100076192 PROCESS FOR PRODUCING 5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-c]PYRIDINE-2-CARBOXYLIC ACID
03/25/2010US20100076190 Method for synthesis of nitroxyl radical
03/25/2010US20100075435 Biotinylated thyroxine
03/25/2010US20100072425 7-ethynyl-2,4,9-trithiaadamantane and related methods
03/24/2010CN101679452A Marking reagents bearing diazo and nitro functions, methods for the synthesis of such reagents and methods for detecting biological molecules
03/24/2010CN101679405A 2-aminopyridine analogs as glucokinase activators
03/24/2010CN101679313A Axl kinase inhibitors used in cancer or excess proliferative disease
03/23/2010CA2530449C Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug
03/23/2010CA2521834C Fragrance and flavour compositions comprising benzo[4,5]thieno[3,2-b]pyran-2-one
03/18/2010WO2010029577A2 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
03/18/2010WO2010028981A1 New benzimidazole derivatives
03/18/2010WO2009151256A3 Method for preparing clopidogrel and its derivatives
03/18/2010US20100069375 Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
03/18/2010US20100069371 Thienopyridine and furopyridine kinase inhibitors
03/18/2010US20100069362 Thienopyrimidone compound
03/18/2010US20100065826 Novel fused polycyclic aromatic compound, process for producing the same, and use thereof
03/18/2010CA2736732A1 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
03/18/2010CA2734034A1 New benzimidazole derivatives
03/17/2010EP1654257B1 Aminopyrones and their use as atm inhibitors
03/17/2010EP1644381B1 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug
03/17/2010CN101675058A Process for production of prasugrel hydrochloride having high purity
03/17/2010CN101675056A Heterocyclic compounds and their use as pesticides
03/17/2010CN101675053A Phosphoinositide 3-kinase inhibitor compounds and methods of use
03/16/2010US7678790 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
03/16/2010CA2142867C Biotinylated chemiluminescent labels, conjugates, assays, assay kits
03/11/2010WO2010027875A2 Compounds that modulate intracellular calcium
03/11/2010WO2010027236A2 Fused heterocyclic compound
03/11/2010WO2010027106A1 Novel compound and organic semiconductor material
03/11/2010WO2010026771A1 Nitrogenated heterocyclic compound and salt thereof, and bactericidal agent for agricultural or horticultural applications
03/11/2010WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
03/11/2010US20100063063 Substituted Heteroaryls
03/11/2010US20100063047 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
03/11/2010US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/11/2010CA2734500A1 Compounds that modulate intracellular calcium
03/10/2010EP1896456B1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
03/10/2010EP1556385B1 Heterocyclocarboxamide derivatives
03/10/2010CN101668763A organic semiconductors
03/10/2010CN101668762A Fused thiophenes, methods for making fused thiophenes, and uses thereof
03/09/2010US7674886 Chelation compounds, radionuclides
03/09/2010US7674822 PTP1b inhibitors
03/09/2010US7674803 Thiazolypiperidine derivatives as MTP inhibitors
03/09/2010CA2421819C Isoquinolinone potassium channel inhibitors
03/04/2010WO2010024388A1 Compound for organic thin film transistor and organic thin film transistor using same
03/04/2010WO2010024180A1 Compound for organic thin-film transistor and organic thin-film transistor using same
03/04/2010WO2010023181A1 Thienopyrimidines for pharmaceutical compositions
03/04/2010US20100056548 Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
03/04/2010US20100056514 Thienopyrazoles
03/04/2010CA2735361A1 Thienopyrimidines for pharmaceutical compositions
03/03/2010EP2159223A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
03/02/2010US7671217 3,4-Ethylenedioxythiophene obtained by heating using a copper catalyst with very high selectivity in the absence of a solvent by heterogeneous reaction ofthe solid alone; high vapor pressure of product enables discharging in gaseous form together with an inert gas stream; minimun use of auxillaries
03/02/2010US7671201 Phenyl substituted cyclic derivatives
03/02/2010US7671079 Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
02/2010
02/25/2010WO2010021149A1 Spiro compound capable of inhibiting acid secretion
02/25/2010WO2010019976A2 Porphyrins and metalloporphyrins
02/25/2010WO2009132032A3 Sonic hedgehog modulators
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048890 Conjugated small molecules
02/25/2010US20100048667 Thiolactones
02/25/2010US20100048583 Novel Heterocyclic NF-kB Inhibitors
02/25/2010US20100048558 Thienopyridines
02/25/2010US20100048551 Tricyclic Compounds Useful as Inhibitors of Kinases
02/25/2010US20100048537 Heteroaryl derivatives
02/24/2010EP2155756A1 Processes for the preparation of clopidogrel
02/24/2010EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
02/24/2010EP2155194A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/24/2010EP1585728B1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
02/24/2010CN100591679C Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
02/23/2010USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one
02/23/2010US7666906 β-Benzyloxyaspartate derivatives with amino group on benzene ring
02/18/2010WO2010019930A1 Urea derivatives as inhibitors of map kinases
02/18/2010WO2010018686A1 Nitrogenated heterocyclic derivative, and agricultural or horticultural bactericidal agent
02/18/2010US20100041729 Dithiolopyrrolones compounds and their therapeutic applications
02/18/2010US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth
02/18/2010US20100041643 Thienotriazolodiazepine compound and medicinal use thereof
02/18/2010CA2733247A1 Heterocyclic amide derivatives as ep4 receptor antagonists
02/17/2010EP2152718A2 Process for preparing dorzolamide
02/17/2010EP1828200B1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
02/17/2010EP1383732B1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
02/16/2010US7662846 Selective spirocyclic glucocorticoid receptor modulators
02/16/2010US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis
02/16/2010US7662814 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases
02/16/2010US7662487 Stability; efficiency; hole injection or hole transporting material
02/16/2010CA2562532C Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
02/16/2010CA2539985C Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
02/16/2010CA2346082C Tricyclic .delta.3-piperidines as pharmaceuticals
02/11/2010WO2010016846A1 Heterocyclic modulators of tgr5 for treatment of disease
02/11/2010WO2010015144A1 The hydrosulfate of prasugrel, its pharmaceutical combination and uses thereof
02/11/2010WO2009017719A8 Modulators of ccr9 receptor and methods of use thereof
02/11/2010US20100032655 Field-effect transistor
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 214